Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-22

Clinical Trial Update: Comparison of I-124 PET/CT for the Diagnosis of Thyroid Cancer [Phase 2]

View source ↗

Summary

This document provides an update on a Phase 2 clinical trial evaluating Iodine-124 PET/CT imaging for diagnosing thyroid cancer, which is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Iodine-124 (Iodine-124)

Snippet

Sponsor: Thomas Hope | Conditions: Thyroid Cancer | Phase 2 | Status: RECRUITING